Blog

Blog sidebar
01 Oct 2021

YOUR BANK OF BIOLOGICAL TISSUES

Linking in vivo pharmacokinetic assessments with efficacy endpoints can give a better understanding of the dynamics of drug action, and ANSbioSamples provides the ideal platform to establish these key relationships. With ANSbioSamples, dosing and collection of healthy or pathological tissues can be performed using a variety of customizable paradigms of treatment combining the desired route of administration with more than 20 biological tissue sources. Drug [...]
23 Sep 2021

IRRITABLE BOWEL SYNDROME: CURRENT SITUATION

Irritable Bowel Syndrome (IBS) is a common chronic functional bowel disease with prevalence rates from 5 to 22%. IBS is defined by the coexistence of abdominal pain or discomfort and alteration in bowel habits without obvious organic abnormalities. Various treatments exist in this field, but what is the real current situation? The prescription drug market [...]
22 Sep 2021

Press release – EMulate Therapeutics

ANS Biotech is very happy and proud to collaborate with EMulate Therapeutics on testing their medical device in various pain situations using the ALGOGram™ screening platform. Click here to access to the entire press release.

14 Sep 2021

The incisional pain model now available in mice

Preclinical investigations in postoperative pain: where are we now at ANS Biotech? From theory…. Postoperative pain (POP) is defined as a transient but extremely strong activation of the nociceptive network. Mechanical hyperalgesia is observed by applying force directly on the wounds of patients after various surgical procedures such as inguinal herniorrhaphy, open cholecystectomy and abdominal [...]
07 Sep 2021

Upcoming ALGOGram™ Fall SESSION

The registration for the upcoming ALGOGram™ session is now open! A decision-making guide to accelerate your Pain programs.

10 Aug 2021

ALGOGram™ back to school SESSION: Last call

Last call for the upcoming ALGOGram Back to school session. Don’t miss it! √ A decision-making guide in developing the all-important product profile for your test compounds.

15 Jul 2021

A new readout to meet your needs

The most appropriate test for translational research Von Frey hairs, initially designed by the German physiologist Max von Frey (1852–1932), are today considered as a standard for assessing tactile nociception both at clinical and preclinical levels. Nowadays, the set is made up of twenty nylon monofilaments of various diameters that can induce a force ranging [...]
25 Jun 2021

OSTEOARTHRITIS PAIN: MECHANISMS AND PHARMACOLOGY – 24JUNE2021

Osteoarthritis (OA) of the knee is a complex peripheral joint disorder. This degenerative disease involving several joint tissues is characterized by damages to the articular cartilage. Pain is the primary symptom of OA and is the driving factor for patients to seek medical help. OA-associated pain is described as dull, aching pain that persists over time, but short episodes of more intense pain, known as flares, are also experience by many individuals.

01 Jun 2021

ALGOGram™: highlights from the first half year 2021

ALGOGram™, more and more popular! Key numbers Since the beginning of the year, the two ALGOGram™ sessions have encountered a great success. Through the Spring and Summer sessions: 31 slots have been booked 10 studies have been performed 6 new clients have experienced our unique in vivo screening tool All the ANS Biotech team thanks [...]
31 May 2021

REGISTER NOW FOR ANS BIOTECH NEXT WEBINAR, JUNE 24TH

Osteoarthritis (OA) of the knee is a complex peripheral joint disorder. This degenerative disease involving several joint tissues is characterized by damages to the articular cartilage. Pain is the primary symptom of OA and is the driving factor for patients to seek medical help. OA-associated pain is described as dull, aching pain that persists over time, but short episodes of more intense pain, known as flares, are also experience by many individuals.